Gene: BCL7C
Official Full Name: BAF chromatin remodeling complex subunit BCL7Cprovided by HGNC
Gene Summary: This gene is identified by the similarity of its product to the N-terminal region of BCL7A protein. The BCL7A protein is encoded by the gene known to be directly involved in a three-way gene translocation in a Burkitt lymphoma cell line. The function of this gene has not yet been determined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33382 | BCL7C Knockout cell line (HeLa) | Human | BCL7C | 1:3~1:6 | Negative | Online Inquiry |
KO33383 | BCL7C Knockout cell line (HCT 116) | Human | BCL7C | 1:2~1:4 | Negative | Online Inquiry |
KO33384 | BCL7C Knockout cell line (HEK293) | Human | BCL7C | 1:3~1:6 | Negative | Online Inquiry |
KO33385 | BCL7C Knockout cell line (A549) | Human | BCL7C | 1:3~1:4 | Negative | Online Inquiry |
BCL7C Gene Knockout Cell Lines are specialized cellular models engineered to elucidate the functional role of the BCL7C gene in various biological processes and disease states. This product involves the precise deletion of the BCL7C gene using CRISPR-Cas9 technology, which allows for targeted modifications in the genome. By knocking out this gene, researchers can investigate its regulatory effects on cellular pathways, including its involvement in oncogenesis and immune responses.
The key mechanism of action of the BCL7C Gene Knockout Cell Lines facilitates comprehensive analysis of gene function through the absence of BCL7C expression. This enables researchers to examine downstream signaling cascades, cellular proliferation, differentiation, and apoptosis. The knockout models serve as powerful tools for studying the BCL7C gene's contributions in oncological research, offering insights into potential therapeutic targets for cancer treatment.
The scientific importance of these cell lines cannot be overstated; they have applications in both basic research and clinical settings, particularly in cancer biology, immunology, and genetic disorders. By advancing the understanding of BCL7C's role, these models contribute to the development of novel interventions and personalized medicine strategies.
Compared to traditional gene knockdown methodologies, our BCL7C Gene Knockout Cell Lines offer enhanced specificity, reliability, and reproducibility. The precise gene editing reduces off-target effects, providing a clearer picture of gene function, which is crucial for experimental fidelity.
For researchers and clinicians, investing in this product is essential for advancing their work in genetics and therapeutic development. The ability to model diseases more accurately facilitates breakthroughs in understanding complex biological systems.
Our company brings extensive expertise in the field of genetic engineering and cellular biology, ensuring that our BCL7C Gene Knockout Cell Lines are developed with the highest standards, supporting scientists in their quest for innovative solutions in biotechnology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.